Amedeo's Top 20

Amedeo Smart

Independent Medical Education

10 September 2018

Multidisciplinary Journal Club

  1. Colangeli R, Jedrey H, Kim S, Connell R, et al.
    Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
    N Engl J Med 2018;379:823-833.

  1. Rawshani A, Rawshani A, Franzen S, Sattar N, et al.
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med 2018;379:633-644.

  2. Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, et al.
    Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
    N Engl J Med 2018;379:846-855.

  3. Maddocks K.
    Update on Mantle Cell Lymphoma.
    Blood 2018.

  4. Ho CM, Beck JR, Lai M, Cui Y, et al.
    Malaria parasite translocon structure and mechanism of effector export.
    Nature 2018.

  1. Donadini MP, Bellesini M, Squizzato A.
    Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events.
    JAMA 2018.

  2. Emu B, Fessel J, Schrader S, Kumar P, et al.
    Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
    N Engl J Med 2018;379:645-654.

  3. Reungwetwattana T, Nakagawa K, Cho BC, Cobo M, et al.
    CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol 2018.

  4. Gupta A, Mackay J, Whitehouse A, Godec T, et al.
    Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Lancet 2018.

  5. Duffau H.
    Paradoxes of evidence-based medicine in lower-grade glioma: To treat the tumor or the patient?
    Neurology 2018.

  1. .
    Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.
    N Engl J Med 2018.

  2. Brignole M, Pokushalov E, Pentimalli F, Palmisano P, et al.
    A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
    Eur Heart J 2018.

  3. Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, et al.
    Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
    Ann Neurol 2018.

  4. Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, et al.
    Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
    Lancet 2018.

  5. Vranckx P, Valgimigli M, Juni P, Hamm C, et al.
    Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a mult
    Lancet 2018.

  1. Blake IM, Pons-Salort M, Molodecky NA, Diop OM, et al.
    Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
    N Engl J Med 2018;379:834-845.

  2. .
    Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
    N Engl J Med 2018.

  3. .
    Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med 2018.

  4. Tian Y, Ou JJ.
    HBV-specific T cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.
    Hepatology 2018.

  5. Dick RA, Zadrozny KK, Xu C, Schur FKM, et al.
    Author Correction: Inositol phosphates are assembly co-factors for HIV-1.
    Nature 2018.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016